Neither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 3, 2013, Pages 294-298

  Naranbhai, Vivek ^a,b   Samsunder, Natasha ^a   Sandler, Netanya G ^c   Roque, Annalys ^c   Karim, Quarraisha Abdool ^a,d   Ndung'U, Thumbi ^b,e   Carr, William H ^b,e,f   Altfeld, Marcus ^b,e   Douek, Daniel C ^c   Karim, Salim S Abdool ^a,d  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Harvard University ^*  (United States)

^e HARVARD UNIVERSITY   (United States)

^f CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

HIV; I FABP; Immune activation; LPS; Microbial translocation; SCD14; TLR2; TLR4; TLR7 8

Indexed keywords

INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 7; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ARTICLE; CELL ACTIVATION; CELL DAMAGE; CYTOKINE RESPONSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; IN VITRO STUDY; INTESTINE CELL; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; MICROBIAL ACTIVITY; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SPECIES TRANSLOCATION;

ADENINE; ANTI-HIV AGENTS; ANTIGENS, CD14; BACTERIAL TRANSLOCATION; CYTOKINES; FATTY ACID-BINDING PROTEINS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; ORGANOPHOSPHONATES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8; TOLL-LIKE RECEPTORS;

EID: 84880207054     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31828e604b     Document Type: Article

References (18)

1. Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol. 2012;10:655-666.
2. Giorgi JV, Liu Z, Hultin LE, et al. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1993;6:904-912.
3. Naranbhai V, Abdool Karim SS, Altfeld M, et al. Innate immune activation enhances HIV acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. J Infect Dis. 2012;206:993-1001.
4. Begaud E, Chartier L, Marechal V, et al. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology. 2006;3:35.
5. McLaren PJ, Ball TB, Wachihi C, et al. HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV-dependent host factors. J Infect Dis. 2010;202(suppl 3):S339-S344.
6. Jennes W, Evertse D, Borget MY, et al. Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers. Clin Exp Immunol. 2006;143:435-444.
7. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141-155.
8. Redd AD, Dabitao D, Bream JH, et al. Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci U S A. 2009;106:6718-6723.
9. Biasin M, Piacentini L, Lo Caputo S, et al. TLR activation pathways in HIV-1-exposed seronegative individuals. J Immunol. 2010;184: 2710-2717.
10. Naranbhai V, Altfeld M, Abdool Karim Q, et al. Natural killer cell function in women at high risk for HIV acquisition: insights from a micro-bicide trial. AIDS. 2012;26:1745-1753.
11. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-1174.
12. Mureithi MW, Poole D, Naranbhai V, et al. Preservation HIV-1-specific IFNgamma+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial. J Acquir Immune Defic Syndr. 2012;60:124-127.
13. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203: 780-790.
14. Evennett NJ, Petrov MS, Mittal A, et al. Systematic review and pooled estimates for the diagnostic accuracy of serological markers for intestinal ischemia. World J Surg. 2009;33:1374-1383.
15. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009;30:475-487.
16. Burgers WA, Muller TL, Kiravu A, et al. Infrequent, low magnitude HIV-specific T-cell responses in HIV-uninfected participants in the 1% Tenofovir microbicide geltrial (CAPRISA 004). Retrovirology. 2012;9(suppl 2):225.
17. Chang JJ, Lacas A, Lindsay RJ, et al. Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection. AIDS. 2012;26: 533-541.
18. Roberts L, Passmore JA, Williamson C, et al. Genital tract inflammation in women participating in the CAPRISA TFV microbicide trial who became infected with HIV: a mechanism for breakthrough infection? Paper presented at: 18th Conf Retroviruses Opportunistic Infections; February 27, 2011, to March 2, 2011; Boston, MA.